Keywords: new, ph, ii, sa, trial, intercell/merck, co

New Ph II SA trial for Intercell/Merck & Co

Article | 01 September 2008

Print This

Austrian vaccines specialist Intercell says that its partner, US drug major Merck & Co, has initiated a Phase II clinical trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in